- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Asia Pacific Vitamin AD3 market size was valued at US$ 312.4 million in 2024 and is projected to reach US$ 418.6 million by 2030, at a CAGR of 5.0% during the forecast period 2024-2030.
Vitamin AD3 is a combination supplement of fat-soluble vitamins A and D3, primarily used in animal feed to promote growth, bone health, and immune function in livestock and poultry.
The Asia Pacific Vitamin AD3 market is experiencing steady growth, driven by the region's expanding animal husbandry sector. China dominates with a 50% market share, followed by India at 20% and Vietnam at 10%. In 2023, the poultry industry consumed 45% of the total production, with swine farming at 30%. The market saw an 8% increase in demand from the aquaculture sector, particularly for fish feed supplements. Key players include DSM (Netherlands) and Zhejiang Medicine Co. (China), holding a combined 45% market share in the region. The industry is investing in stable formulations, with a 12% increase in R&D spending on microencapsulation technologies in 2023. Challenges include volatility in raw material prices, with a 7% increase in vitamin A precursor costs impacting profit margins. Regulatory changes in China's feed additive policies led to a 5% market growth in premix formulations. The market is benefiting from increasing consumer awareness of food quality, driving a 10% growth in fortified animal products demand.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Vitamin AD3. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Vitamin AD3, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Vitamin AD3, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin AD3. This report contains market size and forecasts of Vitamin AD3 in Asia Pacific, including the following market information:
We surveyed the Vitamin AD3 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
• China
• India
• Japan
• South Korea
• Australia
• Thailand
• Indonesia
• Feed Grade
• Food Grade
• Medical Grade
• Breeding Industry
• Food Industry
• Pharmaceutical Industry
• DSM Nutritional Products
• BASF SE
• Zhejiang Medicine Co., Ltd.
• Zhejiang NHU Company Ltd.
• Adisseo
• Glanbia plc
• Bluestar Adisseo Company
• Kingdomway Nutrition, Inc.
• Vedan International
• Divi
1.1 Product Overview and Scope of Vitamin AD3
1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Feed Grade
1.2.3 Food Grade
1.2.4 Medical Grade
1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Breeding Industry
1.3.3 Food Industry
1.3.4 Pharmaceutical Industry
1.4 Asia Pacific Market Growth Prospects
1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)
1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Asia Pacific Production by Manufacturers (2019-2023)
3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Asia Pacific Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Asia Pacific Production
4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)
4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Asia Pacific
5.1.1 Asia Pacific Consumption by Country
5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)
5.1.1 China
5.2.2 India
5.3.3 Japan
5.4.4 South Korea
5.5.5 Australia
5.6.6 Thailand
5.7.7 Indonesia
6.1 Asia Pacific Production Market Share by Type (2019-2024)
6.2 Asia Pacific Revenue Market Share by Type (2019-2024)
6.3 Asia Pacific Price by Type (2019-2024)
7.1 Asia Pacific Production Market Share by Application (2019-2024)
7.2 Asia Pacific Revenue Market Share by Application (2019-2024)
7.3 Asia Pacific Price by Application (2019-2024)
8.1 DSM Nutritional Products
8.1.1 DSM Nutritional Products Corporation Information
8.1.2 DSM Nutritional Products Product Portfolio
8.1.3 DSM Nutritional Products Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 DSM Nutritional Products Main Business and Markets Served
8.1.5 DSM Nutritional Products Recent Developments/Updates
8.2 BASF SE
8.2.1 BASF SE Corporation Information
8.2.2 BASF SE Product Portfolio
8.2.3 BASF SE Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 BASF SE Main Business and Markets Served
8.2.5 BASF SE Recent Developments/Updates
8.3 Zhejiang Medicine Co., Ltd.
8.3.1 Zhejiang Medicine Co., Ltd. Corporation Information
8.3.2 Zhejiang Medicine Co., Ltd. Product Portfolio
8.3.3 Zhejiang Medicine Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Zhejiang Medicine Co., Ltd. Main Business and Markets Served
8.3.5 Zhejiang Medicine Co., Ltd. Recent Developments/Updates
8.4 Zhejiang NHU Company Ltd.
8.4.1 Zhejiang NHU Company Ltd. Corporation Information
8.4.2 Zhejiang NHU Company Ltd. Product Portfolio
8.4.3 Zhejiang NHU Company Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Zhejiang NHU Company Ltd. Main Business and Markets Served
8.4.5 Zhejiang NHU Company Ltd. Recent Developments/Updates
8.5 Adisseo
8.5.1 Adisseo Corporation Information
8.5.2 Adisseo Product Portfolio
8.5.3 Adisseo Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Adisseo Main Business and Markets Served
8.5.5 Adisseo Recent Developments/Updates
8.6 Glanbia plc
8.6.1 Glanbia plc Corporation Information
8.6.2 Glanbia plc Product Portfolio
8.6.3 Glanbia plc Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Glanbia plc Main Business and Markets Served
8.6.5 Glanbia plc Recent Developments/Updates
8.7 Bluestar Adisseo Company
8.7.1 Bluestar Adisseo Company Corporation Information
8.7.2 Bluestar Adisseo Company Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Bluestar Adisseo Company Main Business and Markets Served
8.7.4 Bluestar Adisseo Company Recent Developments/Updates
8.8 Kingdomway Nutrition, Inc.
8.8.1 Kingdomway Nutrition, Inc. Corporation Information
8.8.2 Kingdomway Nutrition, Inc. Product Portfolio
8.8.3 Kingdomway Nutrition, Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Kingdomway Nutrition, Inc. Main Business and Markets Served
8.8.5 Kingdomway Nutrition, Inc. Recent Developments/Updates
8.9 Vedan International
8.9.1 Vedan International Corporation Information
8.9.2 Vedan International Product Portfolio
8.9.3 Vedan International Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Vedan International Main Business and Markets Served
8.9.5 Vedan International Recent Developments/Updates
8.10 Divi
Frequently Asked Questions ?
